Del Mar, CA, United States of America

Roland Blantz

This inventor holds 1 USPTO granted patent. Top assignee: Novacardia, Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Blantz. Retrieved from https://idiyas.com/inventor/roland-blantz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roland Blantz: Innovator in Diuretic Pharmaceutical Composition

Introduction

Roland Blantz is a notable inventor based in Del Mar, California. He has made significant contributions to the field of pharmaceuticals, particularly in the area of diuretics. His innovative work focuses on improving renal function in individuals with impaired health.

Latest Patents

Blantz holds a patent for a method of improved diuresis in individuals with impaired renal function. The patent discloses a pharmaceutical composition that includes a therapeutically effective amount of KW-3902, or its derivatives, combined with a non-adenosine modifying diuretic. This invention outlines methods for inducing a diuretic effect in animals through the administration of this composition.

Career Highlights

Throughout his career, Roland Blantz has been associated with Novacardia, Inc., where he has furthered his research and development efforts. His work has been instrumental in advancing therapeutic options for patients with renal impairments.

Collaborations

Blantz has collaborated with notable colleagues, including Howard C Dittrich and Kenneth J Widder. These partnerships have contributed to the success of his innovative projects and the development of effective pharmaceutical solutions.

Conclusion

Roland Blantz's contributions to the field of pharmaceuticals, particularly in diuretic compositions, highlight his role as an influential inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…